Next 10 |
2024-07-02 11:49:49 ET More on Moderna, Pfizer, etc. Pfizer: It Could Be A Bargain Moderna: Really Strong Competition Novavax seeks FDA authorization for updated JN.1 COVID shot Wall Street Lunch: Pfizer Looks To Take Next Step In Weight-Loss Drugs ...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...
2024-06-27 14:21:43 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks to buy now reflect a more dynamic shift in investor focus of late. Over the past few years, the biotech space attracted plenty of investor interest, driven by the Covid-19 ...
2024-06-26 10:47:03 ET Novavax, Inc. (NVAX) NVAX is trading DOWN for the last 4 days, and it at trading at $13.72 with volume of 2,036,792 and a one day change of $-0.28 (-2.00%). Novavax, Inc. has a 52-week low of 3.53 and a 52-week high of $23.86. The business's 50-day moving aver...
2024-06-24 12:41:43 ET More on Novavax Novavax: New Chapter, Questions Remain Novavax: Bird Flu And COVID-19 Headlines Trigger Rally Novavax, Inc. (NVAX) Jefferies 2024 Global Healthcare Conference (Transcript) Novavax seeks FDA authorization for updated JN.1...
Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine PR Newswire Novavax's JN.1 COVID-19 vaccine is active against current circulating strains, including KP.2 and KP.3 GAITHERSBURG, Md. , Ju...
2024-06-20 15:02:43 ET Summary Novavax, Inc. secured a lucrative deal with Sanofi, receiving potentially $1.2 billion in cash and future royalties for Covid vaccines. The deal significantly improved Novavax's financial position, but the stock has already rallied from $4 to $14, li...
2024-06-18 10:29:52 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It was not long ago that Novavax (NASDAQ: NVAX ) was among the stocks with high short interest. The stock had been trending lower for an extended period. However, with one posit...
2024-06-17 09:06:25 ET Summary Novavax has seen a surge in stock price due to recent COVID-19 and bird flu vaccine developments, reaching over $27 per share. The company is making headlines with updates on their COVID-19 vaccine, bird flu vaccine, and potential FDA approval, with ...
2024-06-14 15:22:07 ET More on Novavax Novavax: Sanofi Partnership Revitalizes My Magnum Opus FDA recommends KP.2 strain be used in updated COVID-19 shots FDA selects JN.1 variant for next COVID vaccine campaign Novavax, Inc. (NVAX) Jefferies 2024 Global Heal...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...
2024-06-26 10:47:03 ET Novavax, Inc. (NVAX) NVAX is trading DOWN for the last 4 days, and it at trading at $13.72 with volume of 2,036,792 and a one day change of $-0.28 (-2.00%). Novavax, Inc. has a 52-week low of 3.53 and a 52-week high of $23.86. The business's 50-day moving aver...